GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy
Figure 10 Although emerging evidence links xenobiotics, such as antibiotics (most commonly prescribed pharmaceuticals), glyphosate (most widely used herbicide), and microplastics (MPs)(ubiquitous emerging environmental contaminant) with anxiety and depression, studies remain limited and mechanisms of action are poorly understood (Zhang et al., 2021a
According to the International Foundation of Employee Benefit Plans, GLP1 prescriptions accounted for 10.5% of annual pharmacy claims in 2025 across many employersponsored plans, a sharp increase from 6.9% in 2023
Airflow distribution in the human lung and its influence on particle deposition
It addresses the root imbalances that keep patients stuck in cycles of pain, fatigue, and relapse